Dr. Vasyl Vasko of the Uniformed Services University of the Health Sciences said that some anti-cancer treatments may shrink tumors but produce more cancer stem cells, which then metastasize as a way to survive the therapy

The research which was presented at the American Association for Cancer Research’s second International Conference on Molecular Diagnostics in Cancer Therapeutic Development, said the cancer stem-cell markers include Nanog and BMI1, both of which contribute to stem cells’ defining ability to renew themselves and differentiate into different cell types. Vasko said these same molecules are found in embryonic stem cells.

“This may help explain why the expression of stem-cell markers has been associated with resistance to chemotherapy and radiation treatments and poor outcome for patients with cancers including prostate, breast and lung cancers,” Vasko said Friday in a release.

Link


  • Stem cell research may increase the chance of bowel cancer survival
  • Researchers Trying To Use Umbilical Cord Stem Cells Nanoparticles To Treat Cancer Better
  • US Anti-Aging Products Demand to Exceed $30 Billion in 2009
  • McGill Draws Breast Cancer Gene Profile
  • Researchers Identified Stem Cells in Colorectal Tumors
  • Texas Study Reveals Stem Cell Treatment Not Useful To Treat Breast Cancer
  • Cancer Expert at John Hopkins Dies of Cancer
  • Canada Donates $100 Million For Cancer Stem Cell Research
  • Stem Cell Therapy Shows Hope for Patients Suffering form Melanoma
  • Experimental Drug Cyclopamine Shows Promise In Adult Brain Cancer Treatment